Heart Disease News and Research

Latest Heart Disease News and Research

Researchers photograph cystic fibrosis protein interaction

New microscopic pictures show the first-ever physical evidence of interaction between two proteins involved in Cystic Fibrosis (CF) disease.

10 Dec 2007

ACG offers updated clinical guidance for managing pregnant patients

Physician experts from the American College of Gastroenterology have released an updated educational monograph highlighting the unique clinical challenges of caring for women with chronic digestive disorders during pregnancy and managing GI complications relating to pregnancy.

10 Dec 2007

Greater need for education regarding blood borne viruses

A new cohort study could facilitate targeted interventions for adolescent offenders who are at a high risk of hepatitis C (HCV) infection and obesity related liver disease.

10 Dec 2007

Winter flu doubles the risk of heart attacks and stroke

Scientists in Britain say a dose of winter infections such flu can double the risk of heart attacks and strokes.

9 Dec 2007

Obesity all set to make future generations fatter and sicker

Researchers from the United States and Denmark are warning that unless steps are taken to reverse the growth in the number of obese children, future generations will be both fatter and sicker than their parents.

6 Dec 2007

Closest look ever at native human tissue

Seeing proteins in their natural environment and interactions inside cells has been a long-standing goal.

5 Dec 2007

Growing old can affect the higher-level brain systems that govern cognition

A team of Howard Hughes Medical Institute researchers has shown that normal aging disrupts communication between different regions of the brain.

5 Dec 2007

Myocor receives trial approval for percutaneously implanted iCoapsys system

Myocor, Inc. announced that the U.S. Food and Drug Administration has granted conditional approval of the Valvular and Ventricular Improvement Via iCoapsys Delivery (VIVID) feasibility study.

5 Dec 2007

Implanting embryonic cardiac cells prevents arrhythmias

When researchers at Cornell, the University of Bonn and the University of Pittsburgh transplanted living embryonic heart cells into cardiac tissue of mice that had suffered heart attacks, the mice became resistant to cardiac arrhythmias, thereby avoiding one of the most dangerous and fatal consequences of heart attacks.

5 Dec 2007

Research institutes from Finland and Singapore develop remote healthcare services

VTT Technical Research Centre of Finland and A*STAR Agency for Science, Technology and Research from Singapore have developed remote healthcare services that allow patients to be treated globally independent of time and location and irrespective of the solutions provided by hardware and data system suppliers. In Finland, the first trial services for treating cardiac patients and patients suffering from chronic illnesses have been promising.

5 Dec 2007

Honey a cheaper and more effective treatment for children's coughs than cough medicine

Experts in the United States say when it comes to children's coughs, natural honey offers a cheaper and more effective alternative to expensive over-the-counter cough medicines.

5 Dec 2007

Popular diabetes drug Avandia linked to osteoporosis

UK fertility regulator wants fewer IVF twin births in order to save lives

The fertility regulator in the UK, the Human Fertilisation and Embryology Authority (HFEA) has called for a reduction in the number of twin births from IVF.

5 Dec 2007

Being fit more important than being fat when it comes to a longer life

The latest research is saying that fitness may be more important when it comes to living longer, than being overweight.

5 Dec 2007

Re-engineered Gleevec reduces heart risks

Using a new bottom-up approach for rational drug design, researchers at Rice University and the University of Texas M. D. Anderson Cancer Center have reengineered the powerful anticancer drug imatinib - best known by its brand name Gleevec - to more specifically target one type of cancer while potentially curbing a rare life-threatening cardiotoxic side effect.

4 Dec 2007